# Easton Capital

> Easton Capital is a VC fund in New York backing Health Care and Medical. See 76 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: New York, United States
- Total investments: 76
- Last investment: Jul 2026
- Lead investor: 34%
- Fund size: $6M
- Last fund: Jul 2009
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/easton-capital-investment-group
- Website: http://www.eastoncapital.com

Easton Capital is a VC fund in New York focused on Health Care and Medical. Easton Capital Investment Group manages approximately$200 million on behalf of a number of significant institutionalinvestors in its three funds, Easton Capital Partners, L.P., Easton Hunt Capital Partners, L.P. and Easton Hunt New York LP. Easton makes investments ranging in size from $2 million to $7.5 million and has strategic co-investmentrelationships with many of its institutional investors which allow it to participate in larger initial and follow-on rounds of funding. Easton has offices in New York and Florida.

## Contacts

5 contacts available for Easton Capital. Shizune tracks 8 team members at Easton Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/easton-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 26 | 34% |
| Medical | 15 | 20% |
| Biotechnology | 15 | 20% |
| Therapeutics | 9 | 12% |
| Medical Device | 9 | 12% |

64 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 18 | 24% |
| Series A | 16 | 21% |
| Funding Round | 11 | 14% |
| Series C | 9 | 12% |
| Series D | 8 | 11% |

11 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 46 | 61% |
| France | 1 | 1% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| John H. Friedman | Founding & Managing Partner | 19 | https://shizune.co/investors/profile/john-h-friedman |
| Charles B. Hughes III | Managing Director General Counsel | 1 | https://shizune.co/investors/profile/charles-b-hughes-iii |
| Francisco Garcia | Managing Director | 3 | https://shizune.co/investors/profile/francisco-garcia |
| Kresimir Letinic | Managing Director | 12 | https://shizune.co/investors/profile/kresimir-letinic |
| Lisa Rhoads | Managing Director | 0 | https://shizune.co/investors/profile/lisa-rhoads |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Trellis Bioscience | Trellis Bioscience develops a technology platform for cellular informatics. The company's technology has applications in the discovery and production of therapeutic monoclonal antibodies. Its cell biology platform provides a direct readout at the single cell level for monitoring activity of diverse cell types and quantifying the impact ofpotential therapeutic interventions. The company is based in San Francisco, California. | $9M | Series C | Jul 16, 2026 |  |
| WellTrackONE | WellTrackONE is a population health management company that offers an end-to-end solution to physician offices, ACOs, integrated delivery networks, hospitals, and other physician networks that helps them administer the Medicare Annual Wellness Visit to all their Medicare patients. The company provides clinical risk management services used to offera comprehensive baseline report for detailing modifiable risk factors, preventative goals, and measurable data.It was founded in 2012 and headquartered in Hilton Head Island, South Carolina. | $1.5M | Venture - Series Unknown | May 17, 2020 |  |
| Claret Medical | Claret Medical, Inc. develops a series of cerebral vascular protection systems for transcatheter aortic valve implantation, surgical, and other interventional procedures. The company’s products include Claret Medical Montage, a dual filter system and percutaneously delivered embolic protection device to capture and remove debris disloged duringvascular procedures; and small (6F) catheters that are inserted into the patient's right arm to protect the patient’s brain during interventional procedures where embolic debris might be released. It offers its products for use as an embolic protection system to capture and remove embolic material (thrombus/debris) that may enter the cerebral vascular system during endovascular procedures. The company was incorporated in 2009 and is based in Santa Rosa, California. | $14.5M | Series C | Oct 23, 2017 |  |
| Kit Check | KitCheck is a provider of a cloud software platform used to offer automated hospital pharmacy kit processing and medication tracking. The company provides cloud-hosted software combined with IoT technology to reduce kit replenishment time by 72-96% while simultaneously delivering higher accuracy and eliminating errors. In addition, the Narc Checkproduct streamlines recording, waste reconciliation, and billing for medications used in the operating room.Kit Check is used across hundreds of hospitals in the U.S. and Canada and tracks over 90% of all kit medication volume in the industry that is digitally tracked. | $20.4M | Series C | Jun 20, 2016 |  |
| Bluesight | Bluesight solves supply chain inefficiencies and reduces risk by providing actionable analytics for every step of the medication lifecycle. Through our suite of Medication Intelligence™ solutions, Bluesight brings simplicity, visibility, and predictability to the complex world of medication management .To date, more than a 1000 U.S. and Canadianhospitals utilize Bluesight solutions to optimize their hospital’s efficiency. Bluesight focuses on providing comprehensive, item- level data that empowers providers to make informed, accurate decisions. These solutions include RFID-enabled inventory management, controlled substance diversion prevention software and medication purchasing optimization. |  | Series C | Jun 20, 2016 |  |
| WellTrackONE | WellTrackONE is a population health management company that offers an end-to-end solution to physician offices, ACOs, integrated delivery networks, hospitals, and other physician networks that helps them administer the Medicare Annual Wellness Visit to all their Medicare patients. The company provides clinical risk management services used to offera comprehensive baseline report for detailing modifiable risk factors, preventative goals, and measurable data.It was founded in 2012 and headquartered in Hilton Head Island, South Carolina. | $1.5M | Series A | Aug 18, 2015 |  |
| Wildflower Health | Wildflower Health focuses on its client's needs and integrates services into existing sustainability programs. Its team is passionate about harnessing user-centered design and technology to deliver products that drive smarter healthcare decisions. It was founded in 2012 and headquartered in San Francisco, California. | $5M | Series B | Jun 26, 2015 |  |
| PerceptiMed | PerceptiMed’s groundbreaking VeriFill™ technology reduces the margin of human error in prescription pill dispensing within retail pharmacies, long-term care facilities and hospitals. Its IdentRx™suite of medication verification and dispensing products are fast, accurate and cost-effective -- providing 100% verification of drug, dosage andmanufacturer for every pill, every time. | $5.4M | Series A | Mar 27, 2015 |  |
| Kit Check | KitCheck is a provider of a cloud software platform used to offer automated hospital pharmacy kit processing and medication tracking. The company provides cloud-hosted software combined with IoT technology to reduce kit replenishment time by 72-96% while simultaneously delivering higher accuracy and eliminating errors. In addition, the Narc Checkproduct streamlines recording, waste reconciliation, and billing for medications used in the operating room.Kit Check is used across hundreds of hospitals in the U.S. and Canada and tracks over 90% of all kit medication volume in the industry that is digitally tracked. | $12M | Series B | Jan 12, 2015 |  |
| Bluesight | Bluesight solves supply chain inefficiencies and reduces risk by providing actionable analytics for every step of the medication lifecycle. Through our suite of Medication Intelligence™ solutions, Bluesight brings simplicity, visibility, and predictability to the complex world of medication management .To date, more than a 1000 U.S. and Canadianhospitals utilize Bluesight solutions to optimize their hospital’s efficiency. Bluesight focuses on providing comprehensive, item- level data that empowers providers to make informed, accurate decisions. These solutions include RFID-enabled inventory management, controlled substance diversion prevention software and medication purchasing optimization. | $12M | Series B | Jan 12, 2015 |  |

10 of 76 investments shown.

## Co-investors
- [New Science Ventures](https://shizune.co/investors/profile/new-science-ventures) — VC Fund, 10 deals together
- [New Leaf Venture Partners](https://shizune.co/investors/profile/new-leaf-venture-partners) — VC Fund, 7 deals together
- [Boston Millennia Partners](https://shizune.co/investors/profile/boston-millennia-partners) — VC Fund, 6 deals together
- [Forbion Capital Partners](https://shizune.co/investors/profile/forbion-capital-partners) — VC Fund, 6 deals together
- [LionBird](https://shizune.co/investors/profile/lionbird) — VC Fund, 6 deals together
- [Morgenthaler Ventures](https://shizune.co/investors/profile/morgenthaler-ventures) — VC Fund, 6 deals together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Easton Capital invest in?

Easton Capital invests primarily in Health Care, Medical and Biotechnology startups, most often at Series B and Series A stage. Most of the 76 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Easton Capital?

Public channels for Easton Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Easton Capital?

The team at Easton Capital includes John H. Friedman (Founding & Managing Partner), Charles B. Hughes III (Managing Director General Counsel) and Francisco Garcia (Managing Director), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co